Researchers isolate marine compound that may halt deadly brain-eating amoeba infections

Brain-eating amoebas are notoriously difficult to treat and have a mortality rate that is almost 100%. The article notes that researchers have now isolated a compound from the sea that could potentially stop the disease.

The discovery is described as a possible treatment, but the report does not provide details on clinical testing, approval status, or timelines. It remains an early‑stage finding that could lead to further development.

If the compound proves effective in later studies, it could represent a significant advance for a condition that currently has no reliable therapy.